Long-Term Efficacy of Occipital Nerve Stimulation for Medically Intractable Cluster Headache
| Autor: | Christian Lucas, Christelle Créac’h, Béchir Jarraya, N. Buisset, Dominique Valade, François Caire, Pierric Giraud, Laurie Tran, Stephan Chabardes, Jean Régis, Stéphane Derrey, Aurelie Leplus, Frederic Bourdain, Anne Donnet, Sylvie Raoul, Jimmy Voirin, Caroline Roos, Jocelyne Bloch, Michel Lanteri-Minet, Philippe Rigoard, Evelyne Guegan-Massardier, Denys Fontaine, Bich Dang-Vu, Sophie Colnat-Coulbois, Coralie Cruzel, Serge Blond |
|---|---|
| Přispěvatelé: | Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ) |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Adult
Quality of life medicine.medical_specialty Cluster headache Visual analogue scale Electric Stimulation Therapy 03 medical and health sciences 0302 clinical medicine Occipital nerve stimulation Refractory 030202 anesthesiology Internal medicine Humans Medicine Peripheral Nerves Aged Intractable business.industry Neuromodulation Middle Aged medicine.disease 3. Good health Treatment Outcome Migraine Anxiety Female Surgery [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] Neurology (clinical) medicine.symptom business Complication 030217 neurology & neurosurgery |
| Zdroj: | Neurosurgery Neurosurgery, Lippincott, Williams & Wilkins, 2021, 88 (2), pp.375-383. ⟨10.1093/neuros/nyaa373⟩ |
| ISSN: | 0148-396X |
| Popis: | International audience; BACKGROUND: Occipital nerve stimulation (ONS) has been proposed to treat refractory chronic cluster headache (rCCH) but its efficacy has only been showed in small short-term series. OBJECTIVE: To evaluate ONS long-term efficacy in rCCH. METHODS: We studied 105 patients with rCCH, treated by ONS within a multicenter ONS prospective registry. Efficacy was evaluated by frequency, intensity of pain attacks, quality of life (QoL) EuroQol 5 dimensions (EQ5D), functional (Headache Impact Test-6, Migraine Disability Assessment) and emotional (Hospital Anxiety Depression Scale [HAD]) impacts, and medication consumption. RESULTS: At last follow-up (mean 43.8 mo), attack frequency was reduced >50% in 69% of the patients. Mean weekly attack frequency decreased from 22.5 at baseline to 9.9 (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|